Abstract
Purpose. To evaluate the effect of human intestinal fluid (HIF) on P-glycoprotein (P-gp)-mediated efflux.
Methods. HIF was obtained from eight healthy volunteers by duodenal aspiration. HIF was applied at different concentrations (0-75%) to the apical compartment of the Caco-2 system. Cyclosporin A (CsA) was used as a model compound for P-gp mediated efflux.
Results. When the bidirectional transport of CsA across Caco-2 monolayers was assessed, a significant polarity in transport could be observed, the absorptive transport being much lower than the secretory transport. Inclusion of HIF resulted in a moderate increase of the absorptive transport, as well as a significant concentration dependent decrease of the secretory transport, without compromising the integrity of the monolayer. Interestingly, a possible gender difference could be detected as inclusion of HIF obtained from female subjects resulted in a decreased absorptive transport of CsA, whereas inclusion of HIF obtained from male subjects resulted in an increased absorptive transport. The P-gp modulating effect of HIF is not caused by a lack of glucose as an energy source for the efflux mechanism when high concentrations of HIF were present in the buffer used.
Conclusions. The results of this study indicate that the contribution of P-gp efflux carriers may be overestimated when using salt buffer solutions as transport media. Additionally, it can be concluded that (presently unidentified) components of HIF may attenuate the P-gp mediated intestinal efflux. The clinical significance of this modulating effect remains to be investigated.
Similar content being viewed by others
References
F. Ingels, S. Deferme, E. Destexhe, M. Oth, G. Van den Mooter, and P. Augustijns. Simulated intestinal fluid as transport medium in the Caco-2 cell culture model. Int. J. Pharm. 232:183–192 (2002).
J. B. Dressman, G. L. Amidon, C. Reppas, and V. P. Shah. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15:11–22 (1998).
E. Galia, E. Nicolaides, D. Hörter, R. Löbenberg, C. Reppas, and J. B. Dressman. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15:698–705 (1998).
P. F. Augustijns, T. P. Bradshaw, L.-S. L. Gan, R. W. Hendren, and D. R. Thakker. Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun. 197:360–365 (1993).
S. D. Turley and J. M. Dietschy. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J. Lipid Res. 19:924–928 (1978).
M. Takayama, S. Itoh, T. Nagasaki, and L. Tanimizu. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79:93–98 (1977).
D. Gurantz, M. F. Laker, and A. F. Hofmann. Enzymatic measurement of choline-containing phospholipids in bile. J. Lipid Res. 22:373–376 (1981).
S. D. van der Werf, G. P. Van Berge Henegouwen, A. T. Ruben, and D. M. Palsma. Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive. J. Hepatol. 4:318–326 (1987).
A. Lindahl, A.-L. Ungell, L. Knutson, and H. Lennernäs. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm. Res. 14:497–502 (1997).
V. Gray and J. B. Dressman. Simulated intestinal fluid, TS-change to 6.8. Pharmacop. Forum 22:1943–1945 (1996).
D. F. Evans, G. Pye, R. Bramley, A. G. Clark, T. J. Dyson, and J. D. Hardcastle. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035–1041 (1988).
P. Janowitz, W. Swobodnik, J. G. Wechsler, A. Zöller, K. Kuhn, and H. Ditschuneit. Comparison of gall bladder bile and endoscopically obtained duodenal bile. Gut 31:1407–1410 (1990).
G. Choudhuri, D. K. Agarwal, V. A. Saraswat, T. S. Negi, R. Saxena, and V. K. Kapoor. Is duodenal bile representative of gallbladder bile? A comparative study. Scand. J. Gastroenterol. 28:920–923 (1993).
A. Venkataramani, R. M. Strong, D. S. Anderson, I. T. Gilmore, K. Stokes, and A. F. Hofmann. Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am. J. Gastroenterol. 93:434–441 (1998).
O. Rosmorduc, B. Hermelin, and R. Poupon. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 120:1459–1467 (2001).
M. Uhr, F. Holsboer, and M. B. Muller. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J. Neuroendocrinol. 14:753–759 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deferme, S., Tack, J., Lammert, F. et al. P-Glycoprotein Attenuating Effect of Human Intestinal Fluid. Pharm Res 20, 900–903 (2003). https://doi.org/10.1023/A:1023891320858
Issue Date:
DOI: https://doi.org/10.1023/A:1023891320858